Ignite Creation Date:
2024-05-06 @ 1:02 PM
Last Modification Date:
2024-10-26 @ 1:07 PM
Study NCT ID:
NCT03913143
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2022-03-17
First Post:
2019-02-21
Brief Title:
A Study to Evaluate Efficacy Safety Tolerability and Exposure After a Repeat-dose of Sepofarsen QR-110 in LCA10 ILLUMINATE
Sponsor:
ProQR Therapeutics
Organization:
ProQR Therapeutics
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Retinal Disease |
| Leber Congenital Amaurosis 10 |
| Blindness |
| Leber Congenital Amaurosis |
| Vision Disorders |
| Sensation Disorders |
| Neurologic Manifestations |
| Eye Diseases |
| Eye Diseases Hereditary |
| Eye Disorders Congenital |